Comparison of the peripheral blood eosinophil count using near-patient testing and standard automated laboratory measurement in healthy, asthmatic and COPD subjects
Near-patient testing (NPT) allows clinical decisions to be made in a rapid and convenient manner and is often cost effective. In COPD the peripheral blood eosinophil count has been demonstrated to have utility in providing prognostic information and predicting response to treatment during an acute e...
Auteurs principaux: | Hambleton, K, Connolly, C, Borg, C, Davies, J, Jeffers, H, Russell, R, Bafadhel, M |
---|---|
Format: | Journal article |
Publié: |
Dove Press
2017
|
Documents similaires
-
Can NPT be used to distinguish eosinophilic inflammatory phenotypes in COPD?
par: Hambleton, K, et autres
Publié: (2016) -
The peripheral blood eosinophil count as a biomarker of eosinophilic airway inflammation in patients with asthma and COPD. Experience from a single centre
par: Shrimanker, R, et autres
Publié: (2017) -
Characterising non-eosinophilic COPD
par: Hambleton, K, et autres
Publié: (2015) -
Peripheral blood eosinophil drop-to-drop variation in patients with COPD using near patient testing: a small validation study
par: Jeffers, H, et autres
Publié: (2017) -
Investigating blood eosinophil count thresholds in patients with COPD
par: Russell, R, et autres
Publié: (2018)